Print
A groundbreaking collaboration between embalmer Richard Hirschman and neuroscientist Dr. Kevin McCairn has thrust a disturbing new theory into public discourse: that strange fibrous clots being discovered in deceased individuals may be linked to an amyloidogenic process triggered by COVID-19 infections and mRNA-based vaccines.
These clots, very visible to the naked eye and described as rubbery, dense, and sometimes over a foot long, may be more than just anomalies—they could be evidence of an unprecedented biomedical event with long-term consequences for human health.
From the Embalming Room to the Laboratory
Richard Hirschman has been embalming bodies since 2001, but in early 2021 he began to notice unusual white fibrous clots forming in the vascular system of the deceased.
These anomalies differed from normal blood clots—more elastic, fibrous, and difficult to break apart. Initially dismissed as “chicken fat clots” by skeptics, Hirschman persisted, sharing his findings with researchers and the public.
Dr. Kevin McCairn, a systems neuroscientist with decades of experience in neurodegenerative disease research, took notice. He offered to analyze the material using advanced lab techniques, including fluorescent and electron microscopy. The results, he says, are alarming.
What Is Amyloidogenesis?
Dr. McCairn explains that the key concern isn’t ordinary fibrin clots but rather the misfolding of proteins into amyloidogenic forms. These protein structures are known for their role in diseases like Alzheimer’s, Parkinson’s, and Creutzfeldt-Jakob disease. Misfolded proteins can induce nearby proteins to also misfold—a templating process that allows the pathology to spread, potentially turning localized damage into a systemic issue.
Using a specialized fluorescent dye called thioflavin, McCairn confirmed that the clots Hirschman had discovered fluoresced intensely—indicating high amyloid content. Unlike typical fibrin, these clots lacked normal blood elements like red cells and platelets.
They also showed unusual structural features under electron microscopy, including twisted, rope-like fibers that resisted breakdown by natural enzymes.
An Engineered Origin?
Dr. McCairn believes these findings fit within a broader, deeply troubling framework. He argues that both the SARS-CoV-2 virus and the spike protein used in mRNA vaccines are engineered bioweapons—constructed under the guise of defensive research but ultimately deployed in a way that unleashed harm globally.
McCairn cites research showing that spike protein fragments accelerate amyloid fibril formation in human tissues, particularly in the brain. He also points to a case study showing localized amyloid activity at a COVID injection site—visible just one day after administration using PET scan imaging. These findings suggest that the spike protein may be more than a viral artifact—it could be a trigger for a self-perpetuating, pathogenic cascade.
The Blood Supply Question
One of the most urgent implications of this research is the potential contamination of the global blood supply. Hirschman notes that some individuals showing these clots had never received a COVID shot—but had received transfusions. If amyloidogenic proteins are transmissible via blood products, the scope of exposure could be far greater than currently acknowledged.
This raises critical questions about blood donor screening and the long-term safety of transfusions. McCairn stresses that even minuscule exposure to spike protein or its derivatives may be enough to initiate a cascade that leads to clot formation and organ damage—potentially years later.
Could This Actually Be Infectious?
Is this phenomenon transmissible in the same way prions are? McCairn says that while these clots show amyloidogenic properties, they don’t yet fully meet the exact criteria for prions, which are more infective and aggressive. However, tests in his lab show that the material is capable of seeding amyloid reactions in fresh human plasma—suggesting an infectious-like behavior that warrants urgent study.
He notes that this kind of “proteinopathy”—where abnormal proteins accumulate and resist breakdown—could lead not only to neurodegenerative disorders but also cardiovascular disease and potentially cancer. The long-term effects are still unknown, and there is currently no known cure.
Systemic Failures and Scientific Silence
Both McCairn and Hirschman are critical of the institutions that have ignored or actively suppressed this research. Universities, public health agencies, and major scientific journals have failed to address mounting evidence, they argue, because doing so would implicate them in one of the most consequential public health failures in history.
McCairn notes that despite multiple Senate hearings and quiet admissions from government officials that SARS-CoV-2 likely originated in a lab, no substantial action has followed. Meanwhile, scientists like himself face de-platforming and ridicule for presenting data that challenges official narratives.
What Comes Next?
According to McCairn, the next steps require urgent, independent research. His lab—funded entirely by public donations—continues to investigate the structure and behavior of these clots.
He encourages others to support independent science and avoid disinformation traps, such as false claims often seeded by disinformation networks to distract from genuine findings.
He warns that unless there is widespread recognition of this amyloid threat, the public will remain vulnerable, not only to the ongoing health consequences but to future medical interventions built on the same flawed and potentially dangerous platforms.
A Wake-Up Call
For those who’ve lost loved ones during the pandemic or suffered long-term effects following vaccination, this emerging science offers both clarity and concern. The discovery of infectious amyloid-like clots could represent one of the most important, yet underreported, medical revelations of our time.
And while the full picture is still unfolding, one thing is certain: what Richard Hirschman began documenting in funeral homes may ultimately reshape how we understand the intersection of biotechnology, public health, and accountability. You can watch the entire interview here.
